Homepage
Policies & Regulations
New prescriptions for Humira®
January 3, 2025
Pharmacy

Effective January 1, 2025, Humira® (adalimumab) or adalimumab biosimilar will no longer be preferred on the Independence Blue Cross (IBX) Value, Select, and Premium Formularies. New prescriptions are now required for patients (our members) on Humira (adalimumab) or adalimumab biosimilars to access the preferred biosimilar indicated below.

Programs
Ninth platform transition training session available
December 27, 2024
Provider Programs
​Independence Blue Cross continues its series of on-demand training sessions to help providers prepare for our transition to a new claims processing platform – a next generation solution that will help us efficiently deliver new and innovative products and services.
Policies & Regulations
Updates to Concierge Medicine policy
December 17, 2024
Regulatory
​Independence Blue Cross (IBX) recently revised its policy on Concierge Medicine. Effective January 1, 2025, IBX will allow primary care physicians (PCPs) who practice Concierge Medicine to be a part of the IBX network, if they meet our policy requirements. This policy ensures that our members (your patients) have access to quality care without experiencing disruptions or delays.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




Filter to find the news that is relevant to your role.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




       
            Loading...